The purpose of this review is to reflect on the physiological basis of myocardial viability, discuss the imaging tests available that characterize myocardial viability, and summarize the current published reports on the use of these tests in This review aims to elaborate on these issues that are emerging in contemporary practice. We will review the pathophysiological events in ischemic cardiac dysfunction, noninvasive strategies to image viable myocardium, and the current published reports regarding patient outcomes with decisions aided by viability testing.
THE PIVOTAL IMPORTANCE OF VENTRICULAR DYSFUNCTION AND PROGNOSIS
It has been known for close to half a century that left ventricular (LV) function is of prognostic significance in cardiovascular disease. In a 10-year follow up of survival in CASS (Coronary Artery Surgery Study), admittedly in an era when advances in medical therapeutics were only in their infancy, the presence of LV dysfunction represented an important discriminant for benefit from bypass graft surgery (1) .
A striking finding in the same study was the relatively low 10-year mortality of patients who had a normal ejection fraction (EF), irrespective of the number of diseased coronary vessels (1) . The importance of ventricular function has been borne out in multiple investigations spanning several decades; the purported mechanisms of benefit post-revascularization being manifold, extending beyond the treatment of ischemia alone ( Figure 1 ) (1-10).
After injury, the heart undergoes adaptive changes with alterations in geometry and function. The process of remodeling is dictated by hemodynamic and neurohormonal factors (11) , which trigger a cascade of events that alter the interaction of myocytes with each other and with the extracellular matrix. Macroscopically this manifests in changes in size, shape, and wall thickness of the heart. Although initially adaptive, if unchecked, the continued stimulus for these changes leads to deleterious effects in the setting of pre-existing CAD, including progression to symptomatic heart failure and worsening ischemia. Multiple neurohormonal mechanisms established in the pathogenesis of heart failure currently serve as important targets in medical therapy (12) (13) (14) (15) (16) (17) . The importance of these neurohormonal mechanisms is underscored by a recent study (18) quantifying inhomogeneity in myocardial sympathetic innervation using positron emission tomography (PET), which found this to be predictive of cardiac arrest. The study comprised 204 subjects with moderate to severe reduction in LV function. Myocardial sympathetic denervation was quantified using the tracer 11 C-meta-hydroxyephedrine and was predictive of sudden cardiac arrest.
Interestingly, other multivariate predictors of sudden cardiac arrest included enddiastolic volume, serum creatinine, and the absence of angiotensin inhibition. These findings emphasize that the physiological milieu is critical in predicting outcomes in patients with ischemic cardiomyopathy and that evaluation of such patients must extend beyond ischemia testing alone.
Cardiac function is not a dichotomous variable; aspects of function measured using one modality might not be measureable using another. In the area of myocardial viability testing, published reports regarding the indications for revascularization in the context of the extent of potentially reversible LV dysfunction remain controversial. Under the rubric of viability, is it the EF, extent of remodeling, extent of scar, extent of ischemia, duration of dysfunction, or a combination that should drive the strategy to treat?
In isolation, these parameters are useful, but their utility could be more powerful in combination (19) , allowing for a more complete characterization of the entire myocardial substrate. Such an approach has been found to be of clinical utility in a small pilot study (19) ; however, multimodality imaging in the evaluation of myocardial viability has not been studied systematically and is not currently recommended.
MYOCARDIAL VIABILITY:
STUNNING, HIBERNATION,
AND THE MYOCARDIAL SUBSTRATE
Pathophysiologically, myocardial viability refers to those cardiomyocytes that are "alive," defined by cellular, metabolic, and microscopic contractile function (7, 20) . Clinically, hibernating and stunned myocardium are subdivisions with differing but sometimes overlapping characteristics ( Figure 2 ).
The first description of myocardial response to acute coronary occlusion was in a dog model in 1935 (21) . In this experiment, ligation of a large coronary branch vessel resulted in a cyanotic and dilated heart with alterations in contractile function. Nearly half a century subsequent to this description, the notion of the "stunned" myocardium was born (22, 23) .
Abruptly reduced blood flow initially causes contractile dysfunction that persists after blood flow is restored, and this was initially referred as the "hit, run, and stun" phenomenon (22) . Although the exact mechanism remains unclear, it likely represents the response of the myocardium to metabolic aberrations created by acute ischemia. This view is supported by the lack of ultrastructural changes in myocyte appearance (23, 24) and the observation of recovery of function, typically over hours to days (7).
It is clear that markedly depressed LV function in the setting of ischemic cardiomyopathy can be reversed with revascularization (9, 25) . Moreover, those patients with ischemic symptoms and the most severe LV dysfunction appear to benefit most from surgical revascularization. In this scenario, a high periprocedural risk must be weighed against an improvement in late mortality (Central Illustration) (26) . These findings were recently confirmed in a 10-year follow-up of patients with ischemic cardiomyopathy, LV dysfunction (LVEF <35%), and CAD amenable to coronary artery bypass graft (CABG) (27) .
In this study, the rate of death of any cause over 10 years was significantly reduced by an absolute difference of 8% in patients who underwent CABG in addition to OMT compared with those receiving optimal contemporary medical therapy alone (27) .
Hibernating myocardium was initially considered to represent an adaptation to a persistent reduction in Revascularization in Severe LV Dysfunction (32, 36, 37) .
Although conceptually, the distinction between stunned and hibernating myocardium has important clinical implications, both can coexist, and indeed, hibernation might represent an adaptation to repetitive stunning ( Figure 2 ) (7). Revascularization in patients with significant viability has been shown to improve outcomes, cardiac function, and functional class in many observational studies (38) . In patients with significant viable myocardium (>20%) in the setting of ventricular dysfunction, mortality increases when the therapeutic strategy is medical therapy alone (39) , which underscores the importance of identifying these patients to provide effective therapy.
Myocardial substrate characterization could help stratify patients who might benefit from revascularization. In a pilot study that used single-photon emission computed tomography (SPECT) to characterize myocardial function (19) , the spectrum of myocardial abnormalities proved to be complex. In this study, a unique 4-step imaging protocol was implemented that took into account regional rest and This study (19) demonstrated that even after the strict use of these definitions to distinguish myocardial substrate characteristics, different states could coexist within the same patient, and even within the same vascular territory. Moreover, each of these varied pathophysiological states will have differing tendencies to recover after revascularization, which further challenges the ability to predict response to therapy. Similarly, in a substudy comprising 399 patients (40), the presence of inducible ischemia in the setting of moderate to severe LV dysfunction was not found to predict better outcomes with surgical revascularization compared with OMT. These findings held regardless of intention-to-treat, as-treated, or per-protocol analysis. In a very large observational study comprising close to 14,000 patients (41) that used adenosine or exercise SPECT imaging, the presence of significant ischemia in patients in the 
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Assess cardiac size, shape, wall thickness and wall motion Need studies *PET CT and PET CMR are emerging hybrid imaging modalities that have yet to be studied. PET CT could add value by decreasing attenuation artifact by coregistration of anatomic information provided by CT with the metabolic and perfusion data provided by PET. PET CMR holds promise in its potential to combine perfusion, metabolic, and contractile information. 
ROLE OF VIABILITY TESTING IN THE MANAGEMENT OF PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
Published data encompassing viability testing are weighted by small, single-center, observational studies during an era when medical therapies for ischemic heart disease have expanded markedly (8) . found in other studies (77, 78) . There are some important limitations that must be emphasized. First, the substudy was nonrandomized, and <50% of patients enrolled in the study underwent viability testing. Second, viability testing was limited to SPECT or dobutamine echocardiography.
Third, there was inherent bias regarding the decision to pursue viability testing, and the protocols for SPECT imaging varied among the multiple enrollment sites. Fourth, the presence of substantial viability was measured in a binary fashion, whereas the current published paradigm would contend that the concept of viability encompasses a wider spectrum (19) . 
